`

Chugai Pharmabody Research

Biotechnology

Specialities :
Antibody drug discovery
Antibody engineering technology
Innovative antibody drug
Recycling antibody
Sweeping antibody

+1

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
51 - 200

Frequently Asked Questions About Chugai Pharmabody Research

What does Chugai pharmabody research do?+

In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies

What are Chugai pharmabody research's specialties? +

Antibody drug discovery,antibody engineering technology,innovative antibody drug,recycling antibody,sweeping antibody,and bispecific antibody

What is Chugai pharmabody research's industry? +

Chugai pharmabody research operates in the Biotechnology industry.

What is Chugai pharmabody research's revenue? +

Chugai pharmabody research's revenue is 11m - 100m

What is Chugai pharmabody research's company size? +

Chugai pharmabody research has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.